[Treatment of serious infectious diseases in children].
BACKGROUND
Serious systemic infections represent a major challenge to all paediatric departments, hence the importance of having treatment guidelines available.


METHODS
Based on a review of the literature and a meeting of Norwegian paediatricians with an interest in the field, guidelines for the treatment of serious infectious diseases are proposed.


RESULTS
The two main new proposals include once daily dosage of aminoglycosides and increased dosage of aciclovir in the treatment of herpes simplex encephalitis.


CONCLUSIONS
The main objective of the meeting was to maintain a conservative and environmental-friendly antibiotics policy in order to contribute to the prevention of antibiotic resistance.
Krogvold
Lars
L
Seksjon for infeksjonssykdommer, Barnemedisinsk avdeling, Ullevål universitetssykehus, Oslo. lars.krogvold@ulleval.no
Wathne
Karl-Olaf
KO
D000617:Aminoglycosides / Q000008:administration & dosage* / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001170:Arthritis, Infectious / Q000188:drug therapy / Q000382:microbiology; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D004352:Drug Resistance, Microbial; D020803:Encephalitis, Herpes Simplex / Q000188:drug therapy; D006801:Humans; D008581:Meningitis / Q000188:drug therapy / Q000382:microbiology; D010019:Osteomyelitis / Q000188:drug therapy / Q000382:microbiology; D017410:Practice Guidelines as Topic; D011704:Pyelonephritis / Q000188:drug therapy / Q000382:microbiology; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology; D014777:Virus Diseases / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents